Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Direct ✕Axis ESG Integration Strategy Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundAxis ESG Integration Strategy Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaAxis
NAV₹666.3420₹22.8900
NAV date20 Nov 202620 Nov 2026
History13.9 years6.8 years
Expense ratio1.0%1.8%
Stars★★★★★★★★★★
Growth Score75.2027.80

Returns

Nippon India Pharma FundAxis ESG Integration Strategy Fund
1 month+11.40%+6.66%
3 months+3.74%−0.17%
6 months+8.55%+4.33%
YTD+16.94%−3.13%
1 year+15.26%−3.09%
3 years (CAGR)+17.96%+8.47%
5 years (CAGR)+15.40%+5.41%
10 years (CAGR)+16.61%—
Since launch+17.63%+12.87%

Risk

Nippon India Pharma FundAxis ESG Integration Strategy Fund
Volatility14.1%14.1%
Downside volatility9.0%10.3%
Sharpe0.810.14
Sortino1.280.19
Calmar1.220.48
Return / risk1.270.60
Deepest fall−24.02%−24.30%
Days to recover445517
Below its high+0.00%−7.66%

Against benchmark

Nippon India Pharma FundAxis ESG Integration Strategy Fund
Alpha−1.86%—
Beta0.89—
R²89.5%—
Up capture85.2%—
Down capture88.7%—
Tracking error4.8%—
Information ratio−0.69—
Treynor0.12—

Consistency

Nippon India Pharma FundAxis ESG Integration Strategy Fund
Best 1-year+90.70%+70.80%
Middle 1-year+13.13%+9.41%
Worst 1-year−15.12%−16.36%
1-year periods with a loss23.2%28.8%
Middle 3-year+19.82%+13.11%
Positive months63.9%63.9%
Best day+3.40%+3.71%
Worst day−3.21%−3.53%
Worst 5% day−1.38%−1.22%
Positive days53.7%52.6%
NAVs a year247251

SIP of ₹10,000 a month

Nippon India Pharma FundAxis ESG Integration Strategy Fund
5-year XIRR+18.24%+7.32%
5-year value₹9,54,076₹7,24,420
3-year XIRR+14.26%+3.16%
1-year XIRR+22.08%+2.79%

Holdings overlap i

Nippon India Pharma FundAxis ESG Integration Strategy Fund
Nippon India Pharma Fund—8%
Axis ESG Integration Strategy Fund8%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Held by all of them

StockNippon India Pharma FundAxis ESG Integration Strategy Fund
Sun Pharmaceutical Industries Limited11.55%2.77%
IPCA Laboratories Limited2.90%1.35%
Anthem Biosciences Limited1.30%1.67%
Biocon Limited0.97%2.29%
Alkem Laboratories Limited1.82%0.73%
Gland Pharma Limited2.73%0.39%

Sectors and company size

Nippon India Pharma FundAxis ESG Integration Strategy Fund
Large companies29.6%49.8%
Mid companies40.8%13.1%
Small companies28.7%21.2%
Top 10 holdings57.2%49.5%
Largest sectorPharmaceuticals & Biotechnology 75%Finance 13%

Search Growth